Earnings took center stage again with a disappointment from IBM (IBM) and a better-than-expected performance from Morgan Stanley (MS) dividing markets. The Dow fell for its second day in a row. Morgan Stanley gave rise to the financials sector after posting increases in its quarterly earnings and revenue. The New York-based firm joined Citigroup (C) , JPMorgan (JPM) and Bank of America (BAC) in reporting a solid first quarter. Crude oil prices held near the flatline after a weekly reading on inventories showed a decline, though not as steep as analysts anticipated. U.S. stockpiles shrank by 1 million barrels, more than half the drop a week earlier. Abbott Laboratories (ABT) was active after beating estimates on its top- and bottom-line. Sales grew nearly 30% in a year full of acquisitions and product launches.
More from Video
Is Renewable Energy the Defensive Stock Opportunity You're Missing
AMSC CEO discusses that and China challenges.
Takeda Pharmaceutical CEO Talks Big Pharma Trends
One of pharma's biggest CEO's talks M&A action on the exchange.
Real Money Video Wrap: Citi Surges as View of Stability Saves Sentiment
Citi overcame a mixed print to send its stock surging on Monday.
Real Money Video Wrap: Apple Rallies as Services Segment Takes Center Stage
There is a lot of Apple news to chew on Wednesday.
Are Algos Jumping on J&J Headlines?
Are machines jumping on Johnson & Johnson's human risk headlines?
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.